Business description
Seagen Inc. is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union.
Management board & Supervisory board
| CEO |
| David R. Epstein |
| Management board |
| Felix J. Baker, Todd E. Simpson, Charles Romp, Jean I. Liu, Natasha Hernday, Roger D. Dansey, Vaughn B. Himes, Lee Heeson, Peggy Pinkston, Sherry Pudloski, Lu Chen, William Compton |
| Supervisory board |
| Alpna Seth, Daniel G. Welch, David W. Gryska, John A. Orwin, Nancy A. Simonian, Ted Love, Sandra M. Swain, David R. Epstein |
Company data
| Name: |
Seagen Inc. |
| Address: |
21717-30th Drive S.E., Building 3,Bothell, WA 98021, USA |
| Phone: |
+1-425-527-4000 |
| Fax: |
- |
| E-mail: |
contact@seagen.com
|
| Internet: |
https://www.seagen.com/ |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
12-31 |
| Free Float: |
- |
| IPO date: |
2001-03-01 |
Investor relations
| Name: |
Peggy Pinkston |
| IR phone: |
+1-425-527-4160 |
| IR Fax: |
- |
| IR e-mail: |
investors@seagen.com
|
